• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm.

作者信息

Polin R S, Hansen C A, German P, Chadduck J B, Kassell N F

机构信息

Department of Neurosurgery, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

出版信息

Neurosurgery. 1998 Jun;42(6):1256-64; discussion 1264-7. doi: 10.1097/00006123-199806000-00031.

DOI:10.1097/00006123-199806000-00031
PMID:9632183
Abstract

OBJECTIVE

We examined the therapeutic benefits of intra-arterially administered papaverine for treatment of symptomatic cerebral vasospasm after subarachnoid hemorrhage (SAH). Recent advances in microcatheter technology have facilitated endovascular approaches to vessels experiencing vasospasm after SAH. However, despite numerous encouraging anecdotal reports, no rigorous examination of the efficacy of these procedures has been published. Intra-arterial infusion of papaverine has become part of the standard management of vasospasm at some centers.

METHODS

We examined a series of 31 patients undergoing papaverine infusion for the treatment of symptomatic vasospasm after SAH. The patients were a subgroup of the series enrolled in the North American Trial of Tirilizad for Aneurysmal Subarachnoid Hemorrhage. These individuals were matched with patients from the same trial who exhibited similar clinical characteristics (including the degree of vasospasm and the modified Glasgow Coma Scale scores measured at the time of admission and on the day of papaverine infusion) but received medical management alone for vasospasm.

RESULTS

Logistic regression analysis comparing these two groups showed no statistical difference in the 3-month Glasgow Outcome Scale scores between patients receiving papaverine and control subjects (58% favorable outcomes for control subjects versus 45% for patients receiving papaverine).

CONCLUSION

Although isolated series documenting clinical successes have prompted the increased use of papaverine as a treatment for vasospasm after SAH, this series suggests that, as it is currently being used, the drug does not provide added benefits, compared with medical treatment of vasospasm alone. This result does not preclude the possibility that alterations in the timing of or indications for drug treatment might produce beneficial effects.

摘要

相似文献

1
Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm.
Neurosurgery. 1998 Jun;42(6):1256-64; discussion 1264-7. doi: 10.1097/00006123-199806000-00031.
2
Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage.经皮腔内血管成形术治疗动脉瘤性蛛网膜下腔出血后症状性脑血管痉挛的疗效
J Neurosurg. 2000 Feb;92(2):284-90. doi: 10.3171/jns.2000.92.2.0284.
3
Intra-arterial infusion of papaverine combined with intravenous administration of high-dose nicardipine for cerebral vasospasm.动脉内注射罂粟碱联合静脉给予大剂量尼卡地平治疗脑血管痉挛。
Acta Neurochir (Wien). 1995;135(3-4):186-90. doi: 10.1007/BF02187766.
4
Neuroradiologic diagnosis and treatment of vasospasm.血管痉挛的神经放射学诊断与治疗
Neuroimaging Clin N Am. 1997 Nov;7(4):819-35.
5
Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm.
Acta Neurochir (Wien). 1997;139(8):706-11. doi: 10.1007/BF01420042.
6
Predictors of outcome after endovascular treatment of cerebral vasospasm.脑血管痉挛血管内治疗后预后的预测因素。
AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1778-82.
7
Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage.经皮腔内血管成形术和动脉内罂粟碱输注治疗动脉瘤性蛛网膜下腔出血后血管痉挛效果的临床评估
Neurol Res. 1999 Mar;21(2):195-203. doi: 10.1080/01616412.1999.11740918.
8
Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.动脉内注射罂粟碱治疗动脉瘤性蛛网膜下腔出血后的脑血管痉挛。
Surg Neurol. 1999 Jan;51(1):66-74. doi: 10.1016/s0090-3019(97)00370-4.
9
Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm.动脉内注入罂粟碱治疗脑血管痉挛期间的颅内压监测
AJNR Am J Neuroradiol. 1998 Aug;19(7):1319-23.
10
Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm.多次动脉内注射罂粟碱对改善复发性脑血管痉挛患者脑循环时间的疗效。
J Neurosurg. 2004 Mar;100(3):414-21. doi: 10.3171/jns.2004.100.3.0414.

引用本文的文献

1
The Potential Therapeutic Effects of Tadalafil on the Endothelium in a Subarachnoid Hemorrhage Animal Model: Insights from Immunohistochemical Staining.他达拉非对蛛网膜下腔出血动物模型内皮细胞的潜在治疗作用:来自免疫组织化学染色的见解
Curr Issues Mol Biol. 2024 Aug 29;46(9):9555-9564. doi: 10.3390/cimb46090567.
2
Pharmacotherapy in SAH: Clinical Trial Lessons.蛛网膜下腔出血的药物治疗:临床试验经验
CNS Neurol Disord Drug Targets. 2024;23(11):1308-1319. doi: 10.2174/0118715273251761231127095039.
3
Outcome analysis for patients with subarachnoid hemorrhage and vasospasm including endovascular treatment.
蛛网膜下腔出血和血管痉挛患者的结局分析,包括血管内治疗。
Neurol Res Pract. 2023 Nov 2;5(1):57. doi: 10.1186/s42466-023-00283-3.
4
Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血后脑血管痉挛预防和管理的药物治疗选择
Hosp Pharm. 2013 Sep;48(5 Suppl):S2-S9. doi: 10.1310/hpj48S5-S2. Epub 2013 Sep 1.
5
Duration of Vasodilatory Action After Intra-arterial Infusions of Calcium Channel Blockers in Animal Model of Cerebral Vasospasm.钙通道阻滞剂在脑血管痉挛动物模型中动脉内输注后的血管扩张作用持续时间。
Neurocrit Care. 2021 Jun;34(3):867-875. doi: 10.1007/s12028-020-01112-0. Epub 2020 Sep 25.
6
Temporal evolution of vasospasm and clinical outcome after intra-arterial vasodilator therapy in patients with aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血患者动脉内血管扩张剂治疗后血管痉挛的时间演变及临床结局
PLoS One. 2017 Mar 24;12(3):e0174676. doi: 10.1371/journal.pone.0174676. eCollection 2017.
7
Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.蛛网膜下腔出血后难治性血管痉挛的抢救治疗。
Curr Neurol Neurosci Rep. 2015;15(2):521. doi: 10.1007/s11910-014-0521-1.
8
Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?动脉瘤性蛛网膜下腔出血的重症患者的脑血管痉挛:现有证据是否支持不断增加的潜在药物治疗干预措施清单?
Hosp Pharm. 2014 Nov;49(10):923-41. doi: 10.1310/hpj4910-923.
9
Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.动脉瘤性蛛网膜下腔出血所致脑血管痉挛的当前治疗选择:文献综述
Interv Neurol. 2013 Oct;2(1):30-51. doi: 10.1159/000354755.
10
Angiographic features and clinical outcomes of intra-arterial nimodipine injection in patients with subarachnoid hemorrhage-induced vasospasm.蛛网膜下腔出血所致血管痉挛患者动脉内注射尼莫地平的血管造影特征及临床结局
J Korean Neurosurg Soc. 2012 Sep;52(3):172-8. doi: 10.3340/jkns.2012.52.3.172. Epub 2012 Sep 30.